Status:
UNKNOWN
Prospective Register on the Etiologies of Cardiogenic Shock and Their Prognosis at One Year.
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Cardiogenic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Cardiogenic shock (CC) is one of the major challenges of current cardiology. Despite the difficulty of establishing a strict and consensual definition, it is accepted that the CC clinically correspond...
Detailed Description
CC diagnosis remains difficult to carry on admission and is sometimes delayed. Therefore, we would like to compare hemodynamic data from patients with CC status to those admitted for acute heart failu...
Eligibility Criteria
Inclusion
- Patients in Cardiac Shock :
- 90 mmHg hypotension or requiring inotropic or vasopressor support,
- owered cardiac output ( 1.8 L/min/m2) to trans-thoracic cardiac ultrasound with high or normal filling pressures
- peripheral hypoperfusion. patients admitted for acute heart failure (ICA) (Acute pulmonary edema chart or left congestive heart failure without CC sign and with ultrasound FEVG at entry 40%.)
Exclusion
- Pregnant or nursing women
- Age 18 years
- Person of full age under guardianship
- Staying in a health or social facility
- Person not covered by a social security scheme
- Person deprived of liberty
- Shocks from other etiologies
- Patient with initial cardiac arrest
- Patient with cardiogenic shock due to right ventricular dysfunction
- Patient with pulmonary embolism
- Patient with tamponade
- Refusal to participate
Key Trial Info
Start Date :
April 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 4 2023
Estimated Enrollment :
1650 Patients enrolled
Trial Details
Trial ID
NCT04467294
Start Date
April 4 2020
End Date
October 4 2023
Last Update
July 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux de Marseille
Marseille, PACA, France, 13354